Magnasense

About:

Magnasense will create technology for biomarker assays that are easily accessible.

Website: https://www.magnasense.com

Top Investors: National Institutes of Health

Description:

Magnasense is basing its operations on laboratory-developed tests and technologies for patient follow-up during biological drug treatment; quantitative near-patient tests for routine control in clinics and health centers; and rapid tests, including indicative and rapid test results, as well as quantitative home tests for chronic diseases.